Abstract
BACKGROUND: Ovarian cancer is the most dangerous gynecologic cancer and one of the top five causes of cancer death in women. One of the intraoperative strategies to diagnose and manage women with ovarian cancer is by doing intraoperative frozen section examination during surgery, but not all hospitals in Indonesia have this facilities, thus makes it difficult to achieve intraoperative diagnosis, which lead to substandard management of patients with ovarian cancer.
AIM: The purpose of this study is to investigate if one can determine whether an ovarian tumor is benign or not based on the gross appearance of the tumor.
METHODS: This study is a comparative, analytic, and cross-sectional study to compare the results of operator’s assessment with the results of intraoperative frozen section examination in determining malignancy during surgery. After the tumor was removed, it was assessed by operator based on the gross appearance of the tumor whether the tumor was benign or not, then the tumor underwent frozen section examination, and based on the frozen section examination results, the patient was treated accordingly. Both of the results then compared to the histopathologic (paraffin block) results, as the gold standard of pathologic diagnosis.
RESULTS: This study shows that variables ascites, tumor seedings, tumor surface, tumor consistency, tumor lobes, and lymph node enlargement are statistically significant (p < 0.05). The combinations of highly significant variables (p < 0.01) show that a combination of ascites and irregular tumor surface give the suggestions that an ovarian is highly likely a non-benign tumor.
CONCLUSION: In the absence of intraoperative frozen section examination in a hospital, operator’s assessment based on gross appearance of the tumor can be used as a substitute for intraoperative frozen section examination to determine the malignancy of an ovarian tumor during surgery.
Publisher
Scientific Foundation SPIROSKI
Reference16 articles.
1. Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016;93(11):937-44. PMid:27281838
2. Indonesian Ministry of Health. Situation of Cancer Disease. Indonesia: Indonesian Ministry of Health; 2015. Available from: https://depkes.go.id/resources/download/pusdatin/infodatin/infodatin-kanker.pdf [Last accessed on 2022 Feb 17].
3. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97:922-9. https://doi.org/10.1111/j.1471-0528.1990.tb02448.x PMid:2223684
4. Berek JS, Longacre TA, Friedlander M. Ovarian, fallopian tube, and peritoneal cancer. In: Berek and Novak’s Gynecology. 16th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2020. p. 1350-427.
5. Coffey DM, Ramzy I. Frozen Section Library: Gynecologic Pathology Intraoperative Consultation. Berlin, Germany: Springer Science and Business Media; 2011.